YY/T 1912-2023Biological evaluation and testing of medical devices for soft tissue regeneration (English PDF)
用于软组织再生医疗器械的生物学评价与试验
This is a limited preview
Buy now to download the full PDF (20 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1912-2023 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
September 5, 2023
Implementation date
September 15, 2024
Scope
YY/T 1912-2023 is the English-translated version of 用于软组织再生医疗器械的生物学评价与试验.
YY/T 1912-2023 is the Chinese standard "Biological evaluation and testing of medical devices for soft tissue regeneration". Its scope clause reads: This document describes biological evaluation and testing methods for soft tissue regenerative medical devices.
This document is applicable to the biological evaluation of soft tissue regeneration medical devices based on GB/T (Z) 16886. Its clauses include normative reference documents; terms and definitions.
Found what you need?
Document preview — YY/T 1912-2023
National Standard of the People's Republic of China
- ICS
- 11.040.01
- Classification
- C30
Issued by: National Medical Products Administration
Contents
- Foreword
- Introduction
- 1 Scope
- 2 Normative reference documents
- 3 Terms and definitions
1 Scope
This document describes biological evaluation and testing methods for soft tissue regenerative medical devices.
This document is applicable to the biological evaluation of soft tissue regeneration medical devices based on GB/T (Z) 16886.
2 Normative reference documents
The contents of the following documents constitute essential provisions of this document through normative references in the text. Among them, the dated quotations
For undated referenced documents, only the version corresponding to that date applies to this document; for undated referenced documents, the latest version (including all amendments) applies to this document.
GB/T 16886.1 Biological evaluation of medical devices Part 1.Evaluation and testing during risk management process
3 Terms and definitions
The terms and definitions defined in GB/T 16886.1 and the following apply to this document.
3.1 soft tissue
Relative to hard tissues such as bones, tissue that connects, supports, or surrounds other structures and organs of the body.
Note. Soft tissues include tendons, ligaments, fascia, skin, fibrous tissue, fat, and sarcolemma (i.e., connective tissue) as well as muscles, nerves, and blood vessels (not connective tissue).
Weaving) etc.
[Source. ASTMF3515-21,3.1.5, modified]
3.2 regeneration
The replacement, restoration or growth of new functional tissue for tissue failure due to aging or disease, or due to injury or congenital defects.
Loss of tissue caused by collapse.
3.3 tissue
Through their migration, differentiation and proliferation, cells deposit extracellular matrix with normal structure, function and appearance to replace the healing of damaged tissue.
combination process.
[Source.ASTMF3163-22,3.3.7]
3.4 scaffoldscaffold
Biomaterial structures used as matrices and guides for tissue repair and regeneration.
3.5
A cell-free scaffold formed by removing cells from the extracellular matrix through biological, chemical and/or physical treatment.
[Source. ASTMF3163-22, 3.5.18, modified] […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 20 pages — is available in the English PDF.
Referenced standards
How to Download YY/T 1912-2023
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
GB/T 16886.10-2024 — Biological evaluation of medical devices - Part 10: Tests for skin sensitization
GB/T 16886.11-2021 — Biological evaluation of medical devices - Part 11: Tests for systemic toxicity
Secure payment via Stripe
Payments accepted
YY/T 1912-2023
$210.00